MY194675A - Use of parkia speciosa empty pod extract in alleviating cardiac hypertrophy - Google Patents

Use of parkia speciosa empty pod extract in alleviating cardiac hypertrophy

Info

Publication number
MY194675A
MY194675A MYPI2020007134A MYPI2020007134A MY194675A MY 194675 A MY194675 A MY 194675A MY PI2020007134 A MYPI2020007134 A MY PI2020007134A MY PI2020007134 A MYPI2020007134 A MY PI2020007134A MY 194675 A MY194675 A MY 194675A
Authority
MY
Malaysia
Prior art keywords
cardiac hypertrophy
extract
empty pod
parkia speciosa
parkia
Prior art date
Application number
MYPI2020007134A
Inventor
Yusof Kamisah
Hawa Nordin Siti
Jalil Juriyati
Asmadi Yusof Ahmad
Original Assignee
Univ Kebangsaan Malaysia
Univ Pertahanan Nasional Malaysia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Kebangsaan Malaysia, Univ Pertahanan Nasional Malaysia filed Critical Univ Kebangsaan Malaysia
Priority to MYPI2020007134A priority Critical patent/MY194675A/en
Publication of MY194675A publication Critical patent/MY194675A/en

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a new kind of medicinal value or health care function of Parkia speciosa empty pod extract, particularly in alleviating cardiac hypertrophy. In one aspect, the present invention discloses a composition comprising an extract of Parkia speciosa empty pod for use in the reduction of the size of cardiomyocytes associated with cardiac hypertrophy condition, wherein the extract has a concentration ranging from 12.5 to 50.0 ?g/mL.
MYPI2020007134A 2020-12-29 2020-12-29 Use of parkia speciosa empty pod extract in alleviating cardiac hypertrophy MY194675A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI2020007134A MY194675A (en) 2020-12-29 2020-12-29 Use of parkia speciosa empty pod extract in alleviating cardiac hypertrophy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI2020007134A MY194675A (en) 2020-12-29 2020-12-29 Use of parkia speciosa empty pod extract in alleviating cardiac hypertrophy

Publications (1)

Publication Number Publication Date
MY194675A true MY194675A (en) 2022-12-13

Family

ID=84926405

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2020007134A MY194675A (en) 2020-12-29 2020-12-29 Use of parkia speciosa empty pod extract in alleviating cardiac hypertrophy

Country Status (1)

Country Link
MY (1) MY194675A (en)

Similar Documents

Publication Publication Date Title
MX2016010213A (en) Novel pharmaceutical formulations.
PH12017502181A1 (en) Nutritional compositions containing an elevated level of inositol and uses thereof
MY161595A (en) Oral care compositions
GEP20227396B (en) Compounds and their uses for alleviating menopause-associated symptoms
MX2015011255A (en) Flavonoid-based composition for pharmaceutical, nutritional or cosmetic use having potentiated antioxidant action.
MX2019009952A (en) Low-viscosity, high-concentration evolocumab formulations and methods of making the same.
CL2017002306A1 (en) Stable formulation for parenteral administration of tapentadol
CO2019000604A2 (en) Vaginal composition comprising a combination of estrogen and vitamin D
WO2019004788A3 (en) Pharmaceutical composition containing broussochalcone a as active ingredient for prevention or treatment of inflammatory bowel disease
CN102845486A (en) Herbal disinfectant
MY194675A (en) Use of parkia speciosa empty pod extract in alleviating cardiac hypertrophy
MX2009012616A (en) Concentrate esmolol.
MY190399A (en) A composition comprising cistanche and ginkgo extracts, the composition useful for improving memory of a subject
BR112021013006A8 (en) USE OF A COMPOSITION COMPRISING A POLLEN EXTRACT
MY170724A (en) Use of certain trioxygenated benzene derivatives in body fat management
SG10201807034XA (en) A pharmaceutical composition for improving or preventing progression of Chronic Kidney Disease
AU2001241315A1 (en) Use of a composition
CN104146914A (en) Forest scent type perfume
WO2019022475A3 (en) Composition containing tenebrio molitor extract as active ingredient for improving skin wrinkles or moisturizing skin
PL425832A1 (en) Genistein and its composition to be used in treatment of Alzheimer disease
WO2016080666A3 (en) Composition for preventing or treating dental caries and periodontal disease, containing extract of ambrosia trifida l. or fraction thereof as active ingredient
MX2015007347A (en) Gel compositions.
CN106929228A (en) Eliminate the unusual smell perfumed soap
PH22019001537U1 (en) Lip balm
MX2021000282A (en) Composition containing a 7beta-hydroxycholesterol and a lipid vehicle, and its use in the treatment of neoplastic pathologies.